Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	140.98	61.94	-25.71
Graham Fair Price	-38.58	54.78	89.18
PEG	-6.22	-0.18	0.20
Price/Book	12.67	4.13	3.67
Price/Cash Flow	inf	0.00	46.87
Prices/Earnings	239.32	24.95	-7.35
Price/Sales	64.76	7.62	4.63
Price/FCF	inf	0.00	46.87
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-11.90	0.16	-0.18
Operating Margin	-60.73	0.10	-0.26
ROA	-63.72	0.01	-0.03
ROE	-0.12	0.04	-66.79
ROIC	-0.09	0.03	-70.81
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	< 0.005	-108.99
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	0.29	1.29	340.58
EPS QOQ	0.37	1.35	261.84
FCF QOQ	0.33	-1.00	200.00
Revenue QOQ	3.05	-0.27	-91.06
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	54.79	107.68	96.54
Days Sales Outstanding (DSO)	92.93	173.78	87.00
Inventory Turnover	1.64	0.84	-49.12
Debt/Capitalization	0.33	0.34	0.33
Quick Ratio	0.77	0.79	2.21
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	53.24	56.75	6.59
Cash	28.62	15.93	-44.35
Capex	-4.57	0.00	inf
Free Cash Flow	4.17	0.00	inf
Revenue	42.22	30.77	-27.10
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.12	1.13	1.50
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.57	3.19	103.27
Naive Interpretation	Member

06 - Financial Health · Bad

Rating